APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Thrombin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Thrombin Market Outlook and Growth Opportunities 2026

Report ID 17400015042 January 2026197 pages

Choose your research edition.

Industry ResearchHuman Thrombin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Thrombin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Human Thrombin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Thrombin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Thrombin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Thrombin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Thrombin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Thrombin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Thrombin market include RAAS, Hualan Bio, Baxter, Octapharma, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Thrombin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Thrombin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Thrombin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Thrombin market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Thrombin Segment by Company

RAAS

Hualan Bio

Baxter

Octapharma

Kedrion

Grifols

CSL

Human Thrombin Segment by Type

500IU

1000IU

2500IU

Human Thrombin Segment by Application

Hospital

Clinic

Other

Human Thrombin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Human Thrombin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Thrombin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Thrombin significant trends, drivers, influence factors in global and regions.

6. To analyze Human Thrombin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Thrombin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Thrombin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Thrombin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Thrombin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Thrombin industry.

Chapter 3: Detailed analysis of Human Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Thrombin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Thrombin Industry Trends Table 2. Human Thrombin Industry Drivers Table 3. Human Thrombin Industry Opportunities and Challenges Table 4. Human Thrombin Industry Restraints Table 5. Global Human Thrombin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Thrombin Revenue Share by Company (2021-2026) Table 7. Global Human Thrombin Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global Human Thrombin Sales Volume Share by Company (2021-2026) Table 9. Global Human Thrombin Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Human Thrombin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Thrombin Key Company Manufacturing Base & Headquarters Table 12. Global Human Thrombin Company, Product Type & Application Table 13. Global Human Thrombin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 500IU Table 18. Significant Companies of 1000IU Table 19. Significant Companies of 2500IU Table 20. Global Human Thrombin Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 21. Global Human Thrombin Sales Volume by Type (2021-2026) & (K Tons) Table 22. Global Human Thrombin Sales Volume by Type (2027-2032) & (K Tons) Table 23. Global Human Thrombin Sales Volume Share by Type (2021-2026) Table 24. Global Human Thrombin Sales Volume Share by Type (2027-2032) Table 25. Global Human Thrombin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Human Thrombin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Human Thrombin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Human Thrombin Sales Value Share by Type (2021-2026) Table 29. Global Human Thrombin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Human Thrombin Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 34. Global Human Thrombin Sales Volume by Application (2021-2026) & (K Tons) Table 35. Global Human Thrombin Sales Volume by Application (2027-2032) & (K Tons) Table 36. Global Human Thrombin Sales Volume Share by Application (2021-2026) Table 37. Global Human Thrombin Sales Volume Share by Application (2027-2032) Table 38. Global Human Thrombin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Human Thrombin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Human Thrombin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Human Thrombin Sales Value Share by Application (2021-2026) Table 42. Global Human Thrombin Sales Value Share by Application (2027-2032) Table 43. Global Human Thrombin Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 44. Global Human Thrombin Sales by Region (2021-2026) & (K Tons) Table 45. Global Human Thrombin Sales Market Share by Region (2021-2026) Table 46. Global Human Thrombin Sales by Region (2027-2032) & (K Tons) Table 47. Global Human Thrombin Sales Market Share by Region (2027-2032) Table 48. Global Human Thrombin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Human Thrombin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Human Thrombin Sales Value Share by Region (2021-2026) Table 51. Global Human Thrombin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Human Thrombin Sales Value Share by Region (2027-2032) Table 53. Global Human Thrombin Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Human Thrombin Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Human Thrombin Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Global Human Thrombin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Human Thrombin Sales by Country (2021-2026) & (K Tons) Table 58. Global Human Thrombin Sales Market Share by Country (2021-2026) Table 59. Global Human Thrombin Sales by Country (2027-2032) & (K Tons) Table 60. Global Human Thrombin Sales Market Share by Country (2027-2032) Table 61. Global Human Thrombin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Human Thrombin Sales Value Market Share by Country (2021-2026) Table 63. Global Human Thrombin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Human Thrombin Sales Value Market Share by Country (2027-2032) Table 65. RAAS Company Information Table 66. RAAS Business Overview Table 67. RAAS Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. RAAS Human Thrombin Product Portfolio Table 69. RAAS Recent Development Table 70. Hualan Bio Company Information Table 71. Hualan Bio Business Overview Table 72. Hualan Bio Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Hualan Bio Human Thrombin Product Portfolio Table 74. Hualan Bio Recent Development Table 75. Baxter Company Information Table 76. Baxter Business Overview Table 77. Baxter Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Baxter Human Thrombin Product Portfolio Table 79. Baxter Recent Development Table 80. Octapharma Company Information Table 81. Octapharma Business Overview Table 82. Octapharma Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Octapharma Human Thrombin Product Portfolio Table 84. Octapharma Recent Development Table 85. Kedrion Company Information Table 86. Kedrion Business Overview Table 87. Kedrion Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Kedrion Human Thrombin Product Portfolio Table 89. Kedrion Recent Development Table 90. Grifols Company Information Table 91. Grifols Business Overview Table 92. Grifols Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Grifols Human Thrombin Product Portfolio Table 94. Grifols Recent Development Table 95. CSL Company Information Table 96. CSL Business Overview Table 97. CSL Human Thrombin Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. CSL Human Thrombin Product Portfolio Table 99. CSL Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Human Thrombin Distributors List Table 103. Human Thrombin Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Human Thrombin Product Image Figure 2. Global Human Thrombin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Thrombin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Thrombin Sales (2021-2032) & (K Tons) Figure 5. Global Human Thrombin Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Human Thrombin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 500IU Image Figure 10. 1000IU Image Figure 11. 2500IU Image Figure 12. Global Human Thrombin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 13. Global Human Thrombin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Human Thrombin Sales Volume Share by Type (2021-2032) Figure 15. Global Human Thrombin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Human Thrombin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Human Thrombin Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Human Thrombin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 22. Global Human Thrombin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Human Thrombin Sales Volume Share by Application (2021-2032) Figure 24. Global Human Thrombin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Human Thrombin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Human Thrombin Sales Value Share by Application (2021-2032) Figure 27. Global Human Thrombin Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 28. Global Human Thrombin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Human Thrombin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Human Thrombin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Human Thrombin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Human Thrombin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Human Thrombin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Human Thrombin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Human Thrombin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Human Thrombin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Human Thrombin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Human Thrombin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Human Thrombin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Human Thrombin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Human Thrombin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Human Thrombin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Human Thrombin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Human Thrombin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Human Thrombin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 500IU
  • 1000IU
  • 2500IU
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • RAAS
  • Hualan Bio
  • Baxter
  • Octapharma
  • Kedrion
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Thrombin Sales Value (2021-2032)
  4. 1.2.2 Global Human Thrombin Sales Volume (2021-2032)
  5. 1.2.3 Global Human Thrombin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Thrombin Market Dynamics
  1. 2.1 Human Thrombin Industry Trends
  2. 2.2 Human Thrombin Industry Drivers
  3. 2.3 Human Thrombin Industry Opportunities and Challenges
  4. 2.4 Human Thrombin Industry Restraints
3 Human Thrombin Market by Company
  1. 3.1 Global Human Thrombin Company Revenue Ranking in 2025
  2. 3.2 Global Human Thrombin Revenue by Company (2021-2026)
  3. 3.3 Global Human Thrombin Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Thrombin Average Price by Company (2021-2026)
  5. 3.5 Global Human Thrombin Company Ranking (2024-2026)
  6. 3.6 Global Human Thrombin Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Thrombin Company Product Type and Application
  8. 3.8 Global Human Thrombin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Thrombin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Thrombin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Thrombin Market by Type
  1. 4.1 Human Thrombin Type Introduction
  2. 4.1.1 500IU
  3. 4.1.2 1000IU
  4. 4.1.3 2500IU
  5. 4.2 Global Human Thrombin Sales Volume by Type
  6. 4.2.1 Global Human Thrombin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human Thrombin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Human Thrombin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Human Thrombin Sales Value by Type
  10. 4.3.1 Global Human Thrombin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human Thrombin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Human Thrombin Sales Value Share by Type (2021-2032)
5 Human Thrombin Market by Application
  1. 5.1 Human Thrombin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Human Thrombin Sales Volume by Application
  6. 5.2.1 Global Human Thrombin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Thrombin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Human Thrombin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Human Thrombin Sales Value by Application
  10. 5.3.1 Global Human Thrombin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Thrombin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Human Thrombin Sales Value Share by Application (2021-2032)
6 Human Thrombin Regional Sales and Value Analysis
  1. 6.1 Global Human Thrombin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Thrombin Sales by Region (2021-2032)
  3. 6.2.1 Global Human Thrombin Sales by Region: 2021-2026
  4. 6.2.2 Global Human Thrombin Sales by Region (2027-2032)
  5. 6.3 Global Human Thrombin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Thrombin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Thrombin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Thrombin Sales Value by Region (2027-2032)
  9. 6.5 Global Human Thrombin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Thrombin Sales Value (2021-2032)
  12. 6.6.2 North America Human Thrombin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Thrombin Sales Value (2021-2032)
  15. 6.7.2 Europe Human Thrombin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Thrombin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Thrombin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Thrombin Sales Value (2021-2032)
  21. 6.9.2 South America Human Thrombin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Thrombin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Thrombin Sales Value Share by Country, 2025 VS 2032
7 Human Thrombin Country-level Sales and Value Analysis
  1. 7.1 Global Human Thrombin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Thrombin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Thrombin Sales by Country (2021-2032)
  4. 7.3.1 Global Human Thrombin Sales by Country (2021-2026)
  5. 7.3.2 Global Human Thrombin Sales by Country (2027-2032)
  6. 7.4 Global Human Thrombin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Thrombin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Thrombin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Thrombin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Thrombin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Thrombin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Thrombin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Thrombin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Thrombin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Thrombin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Thrombin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Thrombin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Thrombin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Thrombin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Thrombin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Thrombin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Thrombin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Thrombin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Thrombin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Thrombin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Thrombin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Thrombin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Thrombin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Thrombin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Thrombin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Thrombin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Thrombin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Thrombin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Thrombin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Thrombin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Thrombin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Thrombin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Thrombin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Thrombin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Thrombin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Thrombin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Thrombin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Thrombin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Thrombin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Thrombin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Thrombin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Thrombin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Thrombin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Thrombin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Thrombin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Thrombin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Thrombin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Thrombin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Thrombin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Thrombin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Thrombin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Thrombin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Thrombin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Thrombin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Thrombin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Thrombin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Thrombin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Thrombin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Thrombin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Thrombin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Thrombin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Thrombin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Thrombin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Thrombin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Thrombin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Thrombin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Thrombin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Thrombin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Thrombin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Thrombin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Thrombin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Thrombin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Thrombin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Thrombin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Thrombin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Thrombin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Thrombin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Thrombin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Thrombin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Thrombin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Thrombin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Thrombin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Thrombin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Thrombin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Thrombin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Thrombin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Thrombin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RAAS
  2. 8.1.1 RAAS Company Information
  3. 8.1.2 RAAS Business Overview
  4. 8.1.3 RAAS Human Thrombin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 RAAS Human Thrombin Product Portfolio
  6. 8.1.5 RAAS Recent Developments
  7. 8.2 Hualan Bio
  8. 8.2.1 Hualan Bio Company Information
  9. 8.2.2 Hualan Bio Business Overview
  10. 8.2.3 Hualan Bio Human Thrombin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hualan Bio Human Thrombin Product Portfolio
  12. 8.2.5 Hualan Bio Recent Developments
  13. 8.3 Baxter
  14. 8.3.1 Baxter Company Information
  15. 8.3.2 Baxter Business Overview
  16. 8.3.3 Baxter Human Thrombin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Human Thrombin Product Portfolio
  18. 8.3.5 Baxter Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Human Thrombin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Human Thrombin Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Human Thrombin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Human Thrombin Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 Grifols
  32. 8.6.1 Grifols Company Information
  33. 8.6.2 Grifols Business Overview
  34. 8.6.3 Grifols Human Thrombin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Grifols Human Thrombin Product Portfolio
  36. 8.6.5 Grifols Recent Developments
  37. 8.7 CSL
  38. 8.7.1 CSL Company Information
  39. 8.7.2 CSL Business Overview
  40. 8.7.3 CSL Human Thrombin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CSL Human Thrombin Product Portfolio
  42. 8.7.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Thrombin Value Chain Analysis
  2. 9.1.1 Human Thrombin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Thrombin Sales Mode & Process
  6. 9.2 Human Thrombin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Thrombin Distributors
  9. 9.2.3 Human Thrombin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst